All Industries

Top Biotechnology Companies

25 Biotechnology companies, sorted by total funding raised.

25

Companies

$3.2B

Combined Funding

Venture Round

Top Stage

Indexed tracks 25 Biotechnology companies that have collectively raised $3.2B in documented funding. The most-funded biotechnology companies tracked include Seattle Genetics and Immunomedics. Venture Round is the most common funding stage among biotechnology companies in this dataset.

Seattle GeneticsAcquired

Biotechnology company focused on developing and commercializing innovative, empowered monoclonal ...

Bothell, United States1001–5000Biotechnology, cancer_treatment
Corporate Round·$1.0B·Sep 2020
ImmunomedicsAcquired

Biotechnology company focused on the development of antibody-drug conjugates for the treatment of...

Morris Plains, United States201–500Biotechnology, Oncology
Private Equity·$459.0M·May 2020
Beacon Therapeutics

Clinical-stage ophthalmic gene therapy company developing AAV-based treatments for rare and preva...

London, United Kingdom51–200Biotechnology
Series C·$365.0M·Jan 2026
Sinotau

Leading innovative radiopharmaceutical company in China developing next-generation radiopharmaceu...

Guangdong, ChinaBiotechnology, Biotech
Venture Round·$252.0M·Jul 2023
SepternaIPO

Clinical-stage biotechnology company pioneering GPCR drug discovery through its proprietary Nativ...

South San Francisco, United States51–200Biotechnology, Healthcare
Series B·$250.0M·Jul 2023
Terns PharmaceuticalsIPO

Clinical-stage biopharmaceutical company developing small-molecule therapies for serious diseases...

Foster City, United States51–200Biotechnology, Healthcare
Series C·$167.0M·Jan 2021
Hyperion TherapeuticsAcquired

Specialty therapeutics company focused on gastrointestinal and hepatology diseases and programs

South San Francisco, United States51–200Biotechnology, specialty therapeutics
Venture Round·$117.5M·Apr 2011
C
CrucellAcquired

Novel vaccine platform

Leiden, Netherlands201–500Biotechnology, pharmaceuticals
Venture Round·$97.0M·Jan 2001
Aphea.Bio

Belgian agricultural biotech company developing microbial-based biocontrol and biostimulant produ...

Ghent, Belgium51–200Biotechnology, agriculture
Series C·$95.7M·Jul 2023
AccurEdit Therapeutics

Clinical-stage biotechnology company developing in vivo CRISPR gene editing therapies for severe ...

Jiangsu, United StatesBiotechnology
Series A·$75.0M·Aug 2023
Confo Therapeutics

Biotech company developing novel GPCR-targeting therapeutics using conformation-specific nanobodies.

Ghent, BelgiumBiotechnology, pharmaceuticals
Series A·$67.1M·May 2019
EyePointIPO

Clinical-stage biotech developing innovative sustained-release therapeutics for serious retinal d...

Watertown, United States51–200Biotechnology, Manufacturing
Corporate Round·$60.5M·Mar 2018
Mogrify

UK biotech developing cell conversion technology for life-saving cell therapies.

Cambridge, United KingdomBiotechnology, Healthcare
Extension Round·$46.7M·Oct 2023
ActelionAcquired

Small molecule therapies for cardiovascular diseases

Allschwil, Switzerland1001–5000Biotechnology, pharmaceuticals
Series B·$46.0M
Kytopen

Cell engineering platform for faster gene delivery

Cambridge, United StatesBiotechnology
Series B·$42.8M·Apr 2026
RevOpsis Therapeutics

Biopharmaceutical company developing multispecific antibody therapies for retinal and complex dis...

Dover, United States1–10Biotechnology
Seed·$16.5M·Aug 2023
INDEVR, INC

R&D company with 1 SBIR/STTR awards from Department of Health and Human Services.

Boulder, United States11–50Biotech, Healthcare
Series B·$16.0M·Jan 2023
Alpha Fusion

Clinical-stage biotechnology company developing Targeted Alpha Therapy (TAT) drugs using astatine...

Osaka, Japan11–50Biotechnology
Series B·$9.2M·Aug 2023
Agrivida

Enzyme technology for animal feed and agricultural productivity

Medford, United Statesagriculture, Biotechnology
Venture Round·$8.0M·Jul 2019
AzentaIPO

Azenta Life Sciences provides automated sample management, storage solutions, and genomics servic...

Chelmsford, United States1001–5000enterprise software, Biotechnology
Funding undisclosed
Biograil

Breakthrough technology for the oral delivery of biologics

Roskilde, Denmark11–50Biotechnology, drug_delivery
Venture Round·Jul 2025
C
CelgeneAcquired

American biopharmaceutical company known for Revlimid and other blood-cancer and immunology thera...

Summit, United States5001–10000Biotechnology, Pharmaceuticals
Funding undisclosed
Inozyme PharmaAcquired

Biotechnology company developing new medicines to treat rare disorders of calcification with init...

Cambridge, United States11–50Biotechnology, Rare Diseases
Series A·Apr 2019
LC
Luminex CorporationAcquired

Austin, Texas biotech diagnostics company (formerly NASDAQ: LMNX), founded 1995. Acquired by DiaS...

United States501–1000Biotechnology, Diagnostics
Funding undisclosed
Madrigal PharmaceuticalsIPO

Clinical-stage biopharmaceutical company focused on developing therapies for metabolic diseases, ...

Conshohocken, United States51–200Biotechnology, Healthcare
Venture Round·Jan 2016

Frequently Asked Questions

How many Biotechnology companies are tracked on Indexed?

Indexed tracks 25 Biotechnology companies, sorted by total funding raised.

How much funding have Biotechnology companies raised in total?

The Biotechnology companies tracked by Indexed have collectively raised $3.2B in documented funding.

What are the top-funded Biotechnology companies?

The most-funded Biotechnology companies tracked include Seattle Genetics, Immunomedics, Beacon Therapeutics.

Explore More

Other Industries